Comerica Bank Innoviva, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Innoviva, Inc. stock. As of the latest transaction made, Comerica Bank holds 161,419 shares of INVA stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

161,419

Previous 216,617 25.48%

Holding current value

$3.09 Million

Previous $3.55 Million 12.3%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $901,383 - $1.11 Million	-55,198 Reduced 25.48%	161,419 $3.12 Million
Q2 2024 Aug 15, 2024	BUY	$14.4 - $16.4 $467,640 - $532,590	32,475 Added 17.64%	216,617 $3.55 Million
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $1.13 Million - $1.3 Million	-77,407 Reduced 29.6%	184,142 $2.81 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $2.88 Million - $3.8 Million	233,576 Added 835.01%	261,549 $4.2 Million
Q3 2023 Nov 21, 2023	BUY	$12.37 - $13.89 $346,026 - $388,544	27,973 New	27,973 $363,000
Q4 2022 Jan 26, 2023	SELL	$11.8 - $13.78 $133,021 - $155,341	-11,273 Reduced 22.74%	38,290 $0
Q3 2022 Oct 28, 2022	SELL	$11.61 - $15.22 $68,731 - $90,102	-5,920 Reduced 10.67%	49,563 $683,000
Q2 2022 Aug 02, 2022	SELL	$14.32 - $19.88 $5,083 - $7,057	-355 Reduced 0.64%	55,483 $817,000
Q1 2022 Apr 27, 2022	BUY	$15.39 - $20.25 $18,437 - $24,259	1,198 Added 2.19%	55,838 $1.08 Million
Q4 2021 Feb 18, 2022	SELL	$15.91 - $18.72 $57,482 - $67,635	-3,613 Reduced 6.2%	54,640 $942,000
Q3 2021 Nov 22, 2021	SELL	$13.06 - $17.24 $27,099 - $35,773	-2,075 Reduced 3.44%	58,253 $973,000
Q2 2021 Aug 26, 2021	SELL	$11.45 - $13.96 $54,192 - $66,072	-4,733 Reduced 7.27%	60,328 $808,000
Q1 2021 Apr 28, 2021	SELL	$11.06 - $12.87 $67,996 - $79,124	-6,148 Reduced 8.63%	65,061 $777,000
Q4 2020 Jan 28, 2021	BUY	$9.33 - $12.48 $36,713 - $49,108	3,935 Added 5.85%	71,209 $882,000
Q3 2020 Oct 30, 2020	SELL	$10.33 - $14.49 $40,565 - $56,902	-3,927 Reduced 5.52%	67,274 $703,000
Q2 2020 Jul 31, 2020	BUY	$11.49 - $15.26 $65,343 - $86,783	5,687 Added 8.68%	71,201 $995,000
Q1 2020 May 01, 2020	BUY	$8.11 - $15.23 $22,837 - $42,887	2,816 Added 4.49%	65,514 $770,000
Q4 2019 Feb 07, 2020	SELL	$10.28 - $14.38 $1,069 - $1,495	-104 Reduced 0.17%	62,698 $887,000
Q3 2019 Oct 31, 2019	SELL	$10.05 - $14.55 $14,200 - $20,559	-1,413 Reduced 2.2%	62,802 $661,000
Q2 2019 Aug 02, 2019	SELL	$13.1 - $14.95 $40,269 - $45,956	-3,074 Reduced 4.57%	64,215 $0
Q1 2019 May 02, 2019	BUY	$13.69 - $20.06 $7,543 - $11,053	551 Added 0.83%	67,289 $0
Q4 2018 Feb 06, 2019	BUY	$13.96 - $18.26 $6,184 - $8,089	443 Added 0.67%	66,738 $1.34 Million
Q3 2018 Nov 01, 2018	SELL	$13.63 - $15.7 $92,329 - $106,351	-6,774 Reduced 9.27%	66,295 $1.02 Million
Q2 2018 Aug 01, 2018	BUY	$13.44 - $17.59 $698 - $914	52 Added 0.07%	73,069 $1.07 Million
Q1 2018 May 01, 2018	SELL	$13.8 - $16.99 $36,335 - $44,734	-2,633 Reduced 3.48%	73,017 $1.19 Million
Q4 2017 Feb 02, 2018	SELL	$11.73 - $14.75 $33,465 - $42,081	-2,853 Reduced 3.63%	75,650 $1.16 Million
Q3 2017 Nov 06, 2017	BUY	$12.06 - $14.12 $946,746 - $1.11 Million	78,503	78,503 $938,000

Others Institutions Holding INVA

# of Institutions

228

Shares Held

79.1M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account